📋 SKILL.md ▸ 📁 21-羟化酶缺乏症诊断流程/
▸ 📁 72-hour-fasting-test-protocol/
▸ 📁 abpa-comprehensive-management/
▸ 📁 access-digital-resources-for-new-form-medical-textbooks/
▸ 📁 acromegaly-diagnosis-gold-standard/
▸ 📁 acromegaly-differential-diagnosis/
▸ 📁 acth-stimulation-test-for-adrenal-insufficiency/
▸ 📁 acute-heart-failure-four-type-strategy/
▸ 📁 acute-hyperuricemic-nephropathy-prevention-treatment/
▸ 📁 acute-leukemia-fab-classification/
▸ 📁 acute-myocardial-infarction-biomarker-interpretation/
▸ 📁 acute-pancreatitis-severity-classification/
▸ 📁 acute-pancreatitis-somatostatin-anti-inflammatory-protocol/
▸ 📁 acute-pulmonary-thromboembolism-clinical-classification/
▸ 📁 acute-respiratory-failure-classification/
▸ 📁 acute-upper-respiratory-infection-clinical-classification-and-differential-diagnosis/
▸ 📁 acute-upper-respiratory-infection-etiology-and-pathogenesis/
▸ 📁 acute-upper-respiratory-infection-treatment-and-antibiotic-use/
▸ 📁 acute-vasoreactivity-testing-in-ipah/
▸ 📁 addison-bing-shen-shang-xian-wei-xiang-chu-li/
▸ 📁 adpkd-ultrasound-diagnosis-age-stratification/
▸ 📁 adult-onset-still-disease-activity-assessment/
▸ 📁 ai-assisted-clinical-diagnosis/
▸ 📁 aki-diagnosis-criteria/
▸ 📁 alcoholic-liver-disease-ethanol-threshold-diagnosis/
▸ 📁 allergic-purpura-diagnosis/
▸ 📁 alpha-thalassemia-genotype-phenotype-classification/
▸ 📁 alport-syndrome-diagnostic-criteria/
▸ 📁 anca-xiao-xue-guan-yan-you-dao-zhi-liao/
▸ 📁 ankylosing-spondylitis-diagnosis/
▸ 📁 anti-ccp-antibody-in-ra/
▸ 📁 antithrombin-anticoagulation-mechanism/
▸ 📁 aortic-stenosis-hemodynamic-threshold-analysis/
▸ 📁 aortic-stenosis-murmur-severity-assessment/
▸ 📁 aortic-stenosis-severity-echo-criteria/
▸ 📁 aplastic-anemia-hematopoietic-stimulation-therapy/
▸ 📁 ards-auxiliary-examination-selection-and-interpretation/
▸ 📁 ards-diagnostic-criteria-comparison/
▸ 📁 ards-lung-protective-ventilation/
▸ 📁 ards-pathological-staging-and-characteristics/
▸ 📁 ascvd-risk-factor-classification-and-intervention/
▸ 📁 assess-lung-cancer-risk-from-tobacco-exposure/
▸ 📁 asthma-acute-exacerbation-graded-treatment/
▸ 📁 atherosclerosis-inflammatory-pathogenesis/
▸ 📁 atherosclerotic-plaque-classification-and-clinical-outcomes/
▸ 📁 atrioventricular-block-ecg-diagnosis/
▸ 📁 autologous-blood-transfusion-selection/
▸ 📁 avrt-ecg-classification/
▸ 📁 bai-xue-bing-er-ci-da-ji-xue-shuo/
▸ 📁 basic-cardiopulmonary-resuscitation-cab/
▸ 📁 beck-san-lian-zheng-yu-xin-zang-ya-sai-zhen-duan/
▸ 📁 behcets-disease-diagnosis/
▸ 📁 ben-ben-an-te-yi-xing-zhong-du-ji-zhi-fen-xi/
▸ 📁 beta-blocker-use-in-angina-management/
▸ 📁 beta-cell-function-assessment-via-oral-stimulation/
▸ 📁 beta-cell-function-assessment-via-special-stimuli/
▸ 📁 beta-thalassemia-classification-and-severe-features/
▸ 📁 biopsychosocial-model-for-chronic-disease-management/
▸ 📁 bnp-nt-probnp-heart-failure-diagnosis-thresholds/
▸ 📁 bronchiectasis-vicious-cycle-mechanism/
📄 build-index.py ⚙️ build-index.sh ▸ 📁 car-t-cell-generation-selection/
▸ 📁 car-t-complication-identification-and-management/
▸ 📁 car-t-therapy-standard-procedure/
▸ 📁 central-diabetes-insipidus-diagnosis/
▸ 📁 cheng-fen-shu-xue-zhi-chi-yu-an-quan-cuo-shi/
▸ 📁 cheng-ren-xian-tian-xing-xin-zang-bing-fen-lei-yu-zhen-duan/
▸ 📁 chest-tube-drainage-and-negative-pressure-management/
▸ 📁 chinese-hypertension-epidemiology-risk-assessment/
▸ 📁 chronic-bronchitis-diagnostic-criteria/
▸ 📁 chronic-cough-etiologic-diagnosis-pathway/
▸ 📁 chronic-gastritis-precancerous-lesion-management/
▸ 📁 chronic-mitral-regurgitation-follow-up-strategy/
▸ 📁 chronic-mitral-regurgitation-pharmacotherapy/
▸ 📁 chronic-nephritis-diagnosis/
▸ 📁 chronic-nephritis-hypertension-proteinuria-management/
▸ 📁 chronic-nephritis-renal-protection/
▸ 📁 chronic-pancreatitis-etiology-analysis/
▸ 📁 chronic-respiratory-failure-oxygen-therapy/
▸ 📁 ckd-acute-exacerbation-risk-assessment-and-management/
▸ 📁 ckd-blood-pressure-management/
▸ 📁 ckd-definition-staging/
▸ 📁 ckd-epi-2021-egfr-calculation/
▸ 📁 ckd-nutrition-protein-calorie-guidelines/
▸ 📁 clinical-diagnosis-of-primary-liver-cancer-2022-china-guideline/
▸ 📁 cll-diagnostic-criteria-and-immunophenotyping/
▸ 📁 cll-treatment-indication-and-targeted-therapy-selection/
▸ 📁 cml-advanced-phase-tki-transplant-strategy/
▸ 📁 colorectal-high-risk-adenoma-identification/
▸ 📁 copd-diagnosis-criteria/
▸ 📁 copd-stable-phase-assessment-and-treatment-strategy/
▸ 📁 copd-stable-phase-ics-indication-assessment/
▸ 📁 coronary-artery-anatomy-and-perfusion-mapping/
▸ 📁 coronary-artery-fistula-interventional-closure-criteria/
▸ 📁 coronary-artery-spasm-diagnosis-and-treatment/
▸ 📁 crohns-disease-active-phase-treatment/
▸ 📁 ctr-cd-monitoring-and-diagnosis/
▸ 📁 cushings-disease-surgical-management/
▸ 📁 d-dimer-rule-for-acute-pulmonary-thromboembolism-exclusion/
▸ 📁 da-jian-kang-concept-integration-in-medical-curriculum/
▸ 📁 daie-antibiotic-regimen-selection/
▸ 📁 dcm-icd-yiji-yufang-zhizheng/
▸ 📁 diabetes-hypertension-management/
▸ 📁 diagnose-active-multiple-myeloma-using-crab-slim/
▸ 📁 diagnose-adult-onset-still-disease-yamaguchi/
▸ 📁 diagnose-essential-thrombocythemia/
▸ 📁 diagnose-hypersplenism/
▸ 📁 diagnose-relapsing-polychondritis-michet/
▸ 📁 diagnose-tobacco-dependence/
▸ 📁 dili-clinical-classification-and-r-value-calculation/
▸ 📁 disease-and-syndrome-naming-standardization/
▸ 📁 dka-fluid-insulin-therapy/
▸ 📁 drowning-pathophysiology-and-emergency-response/
▸ 📁 duo-fa-xing-gu-sui-liu-zhi-chi-zhi-liao/
▸ 📁 dvt-clinical-signs-and-circumference-measurement/
▸ 📁 dynamic-ecg-monitoring-selection-and-interpretation/
▸ 📁 early-gastric-cancer-endoscopic-treatment-indications/
▸ 📁 ecmo-initiation-indications-and-initial-settings/
▸ 📁 eculizumab-treatment-for-pnh/
▸ 📁 endocrine-metabolic-diagnosis-framework/
▸ 📁 endocrine-metabolic-disease-diagnosis-triad/
▸ 📁 endogenous-hyperinsulinemia-diagnosis/
▸ 📁 er-jian-ban-xia-zhai-xue-liu-dong-li-xue-fen-qi/
▸ 📁 esophageal-cancer-endoscopic-treatment-selection/
▸ 📁 falot-si-lian-zheng-fu-zhu-jian-cha/
▸ 📁 fei-ai-jie-ru-zhi-liao-xuan-ze/
▸ 📁 fibromuscular-dysplasia-ras-pathway/
▸ 📁 folate-deficiency-megaloblastic-anemia-pathogenesis/
▸ 📁 functional-constipation-diet-psych-intervention/
▸ 📁 functional-dyspepsia-subtype-diagnosis-and-treatment/
▸ 📁 functional-neuroendocrine-tumor-classification/
▸ 📁 g6pd-deficiency-pathogenesis-and-clinical-management/
▸ 📁 gallbladder-cancer-risk-assessment-for-gallstone-patients/
▸ 📁 gao-niao-suan-xue-zheng-shen-bing-yu-fang-chu-li/
▸ 📁 gao-wen-huan-jing-ren-ti-san-re-fen-xi/
▸ 📁 gao-xue-ya-xue-liu-dong-li-xue-fen-xi/
▸ 📁 gaoyuan-bing-fa-bing-ji-zhi-fen-xi/
▸ 📁 gerd-diagnosis-and-classification/
▸ 📁 ghd-clinical-assessment-and-subtyping/
▸ 📁 glomerular-hematuria-diagnosis/
▸ 📁 glp-1ra-clinical-application/
▸ 📁 gout-classification-diagnosis-2015-acr-eular/
▸ 📁 grace-risk-stratification-and-treatment-strategy/
▸ 📁 graves-disease-antithyroid-drug-protocol/
▸ 📁 graves-eye-disease-activity-and-severity-assessment/
▸ 📁 graves-eye-disease-tiered-treatment/
▸ 📁 guan-xin-bing-lin-chuang-fen-xing/
▸ 📁 gut-microbiota-composition-function-and-systemic-impact/
▸ 📁 hashimoto-thyroiditis-diagnosis/
▸ 📁 hcm-diagnosis-and-classification/
▸ 📁 heart-failure-classification-by-lvef/
▸ 📁 heart-failure-diuretic-principles/
▸ 📁 hematopoietic-stem-cell-collection-and-preservation/
▸ 📁 hemolytic-anemia-pathogenesis-and-classification/
▸ 📁 hemophilia-clotting-factor-dose-calculation/
▸ 📁 hepatic-encephalopathy-diagnosis-workflow/
▸ 📁 hepatic-encephalopathy-pathogenesis-and-trigger-management/
▸ 📁 hepatocellular-carcinoma-extrahepatic-metastasis-pathways/
▸ 📁 hepatocellular-injury-biomarker-interpretation/
▸ 📁 hepatorenal-syndrome-diagnosis-criteria/
▸ 📁 hepcidin-mediated-anemia-analysis/
▸ 📁 hfrEF-new-quadruple-therapy/
▸ 📁 hla-typing-and-donor-selection-for-allo-hsct/
▸ 📁 hormone-interaction-pattern-analysis/
▸ 📁 hormone-replacement-therapy-for-endocrine-hypofunction/
▸ 📁 hsct-classification-system/
▸ 📁 hyperkalemia-cardiac-protection-emergency/
▸ 📁 hyperkalemia-graded-prevention-and-treatment/
▸ 📁 hyperosmolar-dehydration-fluid-calculation/
▸ 📁 hypertension-cardiovascular-risk-stratification/
▸ 📁 hypertension-drug-treatment-principles/
▸ 📁 hypertriglyceridemia-induced-acute-pancreatitis-assessment/
▸ 📁 hyperuricemia-typing-diagnosis/
▸ 📁 hypoglycemia-whipple-triad-diagnosis/
▸ 📁 hypoparathyroidism-etiology-classification/
▸ 📁 hypoparathyroidism-lab-diagnosis-and-calcium-correction/
▸ 📁 hypoparathyroidism-treatment-management/
▸ 📁 hypopituitarism-etiology-classification/
▸ 📁 hypothalamic-lesion-localization-diagnosis/
▸ 📁 hypothalamic-pituitary-target-gland-feedback-regulation-2/
▸ 📁 hypothalamic-pituitary-target-gland-feedback-regulation/
▸ 📁 i-131-therapy-for-differentiated-thyroid-cancer/
▸ 📁 ibs-diagnosis-criteria/
▸ 📁 ibs-subtype-classification-by-stool-form/
▸ 📁 ibs-visceral-hypersensitivity-assessment/
▸ 📁 ida-diagnostic-criteria/
▸ 📁 ida-three-stage-assessment/
▸ 📁 idiopathic-inflammatory-myopathy-classification/
▸ 📁 igg4-rd-pathogenesis-analysis/
▸ 📁 igg4-related-disease-diagnosis/
▸ 📁 igg4-related-hepatobiliary-disease-diagnosis-and-treatment/
▸ 📁 infective-endocarditis-blood-culture-protocol/
▸ 📁 infective-endocarditis-imaging-diagnostic-criteria/
▸ 📁 insulin-glucose-ratio-for-insulinoma/
▸ 📁 insulin-therapy-indications-principles/
▸ 📁 ipah-diagnosis-criteria-and-exclusion/
▸ 📁 ipah-supportive-care-management/
▸ 📁 ipf-diagnosis-criteria-and-workflow/
▸ 📁 isoniazid-dosing-and-monitoring/
▸ 📁 isth-overt-dic-scoring/
▸ 📁 itp-chu-xue-feng-xian-ping-gu-yu-zhi-liao-qi-dong/
▸ 📁 jie-he-xing-xiong-mo-yan-chou-ye-zhi-liao/
▸ 📁 jing-bi-gao-liu-liang-xi-yang-hfnc-can-shu-she-zhi/
▸ 📁 jones-rheumatic-fever-diagnostic-criteria-2015/
▸ 📁 klinefelter-syndrome-diagnosis-and-testosterone-replacement/
▸ 📁 large-vessel-vasculitis-classification/
▸ 📁 left-heart-failure-vs-severe-asthma-differential-diagnosis/
▸ 📁 left-ventricular-outflow-tract-obstruction-diagnosis/
▸ 📁 leukemia-classification-framework/
▸ 📁 light-criteria-pleural-effusion-differentiation/
▸ 📁 lipid-lowering-drug-combination-therapy/
⚙️ list-skills.sh ▸ 📁 liver-synthetic-function-assessment/
▸ 📁 lower-extremity-arterial-disease-staging-and-diagnosis/
▸ 📁 lower-respiratory-tract-specimen-pathogen-threshold-interpretation/
▸ 📁 lung-abscess-antibiotic-therapy-and-duration-management/
▸ 📁 lung-abscess-diagnostic-workup/
▸ 📁 lung-cancer-bone-metastasis-gamma-scintigraphy-diagnosis/
▸ 📁 lung-cancer-epidemiology-and-global-burden/
▸ 📁 lung-cancer-histopathological-classification/
▸ 📁 lung-cancer-three-tier-prevention/
▸ 📁 malignant-arteriolar-nephrosclerosis-hypertension-treatment/
▸ 📁 mdr-tb-treatment-regimen-selection/
▸ 📁 medical-terminology-bilingual-index-lookup/
▸ 📁 medical-terminology-mapping-for-diagnostic-procedures/
▸ 📁 medical-textbook-hierarchical-editing-system/
▸ 📁 metabolic-alkalosis-etiology-and-targeted-treatment/
▸ 📁 metabolic-syndrome-diagnosis-criteria/
▸ 📁 mitral-stenosis-pulmonary-edema-treatment/
▸ 📁 mitral-stenosis-severity-echo-criteria/
▸ 📁 morning-fasting-hyperglycemia-differentiation/
▸ 📁 myocardial-oxygen-demand-and-ischemia-mechanism-analysis/
▸ 📁 nafld-clinical-diagnosis/
▸ 📁 nafld-lifestyle-intervention-efficacy-threshold/
▸ 📁 nei-ke-xue-jiao-cai-bian-xie-yuan-ze/
▸ 📁 nei-ke-xue-jiao-cai-shi-yong-dui-xiang-pan-duan/
▸ 📁 nephrotic-syndrome-diuretic-therapy/
▸ 📁 nephrotic-syndrome-edema-mechanism-analysis/
▸ 📁 nephrotic-syndrome-proteinuria-pathophysiology/
▸ 📁 nsclc-molecular-pathology-testing/
▸ 📁 numano-vascular-classification-for-takayasu-arteritis/
▸ 📁 nyha-heart-failure-functional-classification/
▸ 📁 obesity-body-fat-assessment/
▸ 📁 obstructive-sleep-apnea-diagnosis-and-severity-grading/
▸ 📁 organic-solvent-common-toxicity-assessment/
▸ 📁 organophosphate-poisoning-severity-grading/
▸ 📁 osteoarthritis-diagnosis-criteria-by-joint/
▸ 📁 osteoporosis-diagnosis-criteria/
▸ 📁 pancreatic-cancer-risk-assessment-and-nutrition-support/
▸ 📁 pancreatic-cancer-tumor-marker-interpretation/
▸ 📁 pbc-diagnosis-criteria/
▸ 📁 peptic-ulcer-drug-treatment-protocol/
▸ 📁 peritoneal-dialysis-mechanical-complications-management/
▸ 📁 pet-ct-lung-cancer-diagnosis-staging/
▸ 📁 pheochromocytoma-paroxysmal-hypertension-triad-assessment/
▸ 📁 pituitary-tumor-classification/
▸ 📁 plasma-osmolarity-calculation/
▸ 📁 pleural-effusion-etiology-diagnosis/
▸ 📁 pleural-effusion-pressure-gradient-calculation/
▸ 📁 pmf-bone-marrow-fibrosis-grading/
▸ 📁 pneumococcal-pneumonia-antibiotic-therapy/
▸ 📁 pneumonia-severity-assessment/
▸ 📁 pnh-iron-supplementation-principles/
▸ 📁 portal-hypertension-collateral-circulation-analysis/
▸ 📁 prca-classification-and-etiology/
▸ 📁 prerenal-to-intrinsic-aki-progression-staging/
▸ 📁 prerenal-vs-atn-urine-differentiation/
▸ 📁 primary-aldosteronism-diagnosis-pathway/
▸ 📁 primary-sjogren-syndrome-diagnosis/
▸ 📁 prolactinoma-diagnosis-and-interference-management/
▸ 📁 protein-c-system-anticoagulation-mechanism/
▸ 📁 proteinuria-definition-classification/
▸ 📁 pte-pathophysiological-assessment/
▸ 📁 pulmonary-aspergillosis-classification-and-diagnosis/
▸ 📁 pulmonary-tuberculosis-diagnosis-and-classification/
▸ 📁 pulmonary-tuberculosis-imaging-diagnosis/
▸ 📁 pulmonary-tuberculosis-microbiological-diagnosis/
▸ 📁 r-iss-staging-for-multiple-myeloma/
▸ 📁 ra-diagnosis-acr-eular-2010/
▸ 📁 ra-stepwise-drug-therapy/
▸ 📁 raas-inhibitors-in-heart-failure/
📄 README_EN.md 📄 README_FR.md 📄 README_JA.md 📄 README_RU.md 📄 README.md ▸ 📁 reducing-proteinuria-with-acei-arb-and-sglt2i/
▸ 📁 refractory-ascites-management/
▸ 📁 refractory-hypertension-definition-and-cause-evaluation/
▸ 📁 renal-artery-occlusion-imaging-selection/
▸ 📁 renal-edema-classification-and-clinical-features/
▸ 📁 renal-transplant-rejection-classification-and-management/
▸ 📁 respiratory-and-metabolic-acidosis-alkali-therapy/
▸ 📁 respiratory-disease-etiology-based-treatment/
▸ 📁 resting-ecg-analysis-principles/
▸ 📁 rheumatoid-arthritis-pathogenesis-analysis/
▸ 📁 rhg-csf-treatment-for-neutropenia/
▸ 📁 rifampicin-rifapentine-tb-treatment/
▸ 📁 sarcoidosis-chest-xray-staging/
▸ 📁 sarcoidosis-diagnostic-triad/
▸ 📁 secondary-hypertension-screening/
▸ 📁 sedative-hypnotic-poisoning-differentiation/
▸ 📁 sheng-li-xing-shi-guan-kang-fan-liu-fang-yu-ji-zhi/
▸ 📁 sheng-zhang-ji-su-bian-fa-xing-dai-xiao-zheng-zhen-duan/
▸ 📁 short-term-glucocorticoid-therapy-in-severe-cases/
▸ 📁 shuang-lin-suan-yan-zhi-liao-gu-zhi-shu-song/
▸ 📁 shuang-xin-zhi-liao-mo-shi/
▸ 📁 siadh-diagnosis-and-differential/
📄 skill-card.md {} skills-index.json ▸ 📁 sle-environmental-triggers-assessment/
▸ 📁 sle-glucocorticoid-therapy/
▸ 📁 sle-自身抗体临床效应预测/
▸ 📁 sledai-lupus-activity-assessment/
▸ 📁 smoking-health-hazards-mechanisms-and-evidence/
▸ 📁 sofa-score-assessment/
▸ 📁 spontaneous-pneumothorax-classification-and-emergency-intervention/
▸ 📁 spontaneous-pneumothorax-conservative-management/
▸ 📁 sputum-specimen-quality-assessment-and-pathogen-diagnosis/
▸ 📁 ssc-shen-wei-xiang-shi-bie-yu-chu-li/
▸ 📁 ssc-subtype-classification/
▸ 📁 sss-diagnosis-and-treatment/
▸ 📁 stable-angina-diagnosis-and-testing/
▸ 📁 statin-therapy-for-secondary-prevention-of-coronary-artery-disease/
▸ 📁 stemis-thrombolytic-eligibility-assessment/
▸ 📁 subacute-thyroiditis-staging-diagnosis/
▸ 📁 sulfonylurea-drug-guidelines/
▸ 📁 sydney-2006-aps-classification-criteria/
▸ 📁 systemic-vasculitis-chapel-hill-classification/
▸ 📁 t2dm-beta-cell-dysfunction-triad-analysis/
▸ 📁 t2dm-glucagon-glp1-axis-dysregulation-analysis/
▸ 📁 t2dm-shuang-zhong-xin-ji-zhi-fen-xi/
▸ 📁 teer-适应证评估/
▸ 📁 tenth-round-clinical-medical-textbook-revision-principles/
▸ 📁 thrombophilia-clinical-identification/
▸ 📁 thyroid-nodule-malignancy-ultrasound-assessment-and-fna-indication/
▸ 📁 thyroid-storm-comprehensive-treatment/
▸ 📁 thyrotoxicosis-clinical-manifestations/
▸ 📁 tocilizumab-use-in-covid-19/
▸ 📁 toxic-exposure-four-element-diagnosis/
▸ 📁 toxic-megacolon-diagnosis-in-ulcerative-colitis/
▸ 📁 translational-and-integrative-medicine-implementation/
▸ 📁 ttp-diagnosis-and-emergency-management/
▸ 📁 type-1-renal-tubular-acidosis-diagnosis/
▸ 📁 ua-nstemi-anti-ischemic-drug-therapy/
▸ 📁 ulcerative-colitis-cancer-surveillance/
▸ 📁 ulcerative-colitis-severity-classification/
▸ 📁 uremic-toxin-classification-and-clinical-impact/
▸ 📁 urinary-tract-infection-antibiotic-therapy-by-type/
▸ 📁 urinary-tract-infection-classification/
▸ 📁 urinary-tract-infection-diagnostic-thresholds/
▸ 📁 urinary-tract-infection-treatment-efficacy-assessment/
▸ 📁 vaughan-williams-抗心律失常药物分类/
▸ 📁 ventricular-preexcitation-ecg-diagnosis-and-ab-typing/
▸ 📁 ventricular-premature-contraction-ecg-diagnosis-and-classification/
▸ 📁 vip-oma-diagnosis-criteria/
▸ 📁 viral-pneumonia-antiviral-treatment/
▸ 📁 viral-pneumonia-diagnosis-and-confirmation/
▸ 📁 vitamin-b12-deficiency-dual-pathogenesis/
▸ 📁 vwds-subtype-diagnosis/
▸ 📁 wei-zhong-zheng-yi-xue-he-xin-shi-jian/
▸ 📁 wen-kang-ti-xing-aiha-zhen-duan-yu-zhi-liao/
▸ 📁 xian-zhi-xing-xin-ji-bing-zhen-duan-yu-jian-bie/
▸ 📁 xin-guan-xue-shen-jing-zheng-zhen-duan/
▸ 📁 xin-shi-ya-li-rong-ji-zhou-qi-fen-xi/
▸ 📁 xue-qing-ji-gan-jian-ce-lin-chuang-yun-yong/
▸ 📁 zhong-du-jiu-zhi-xue-ye-jing-hua-xuan-ze/
▸ 📁 zhong-shu-xing-niao-beng-zheng-fen-lei-yu-san-xiang-yan-bian/
▸ 📁 一氧化碳中毒分级与高压氧治疗/
▸ 📁 上消化道非静脉曲张出血抑酸治疗/
▸ 📁 下消化道出血手术指征/
▸ 📁 中暑风险评估/
▸ 📁 中枢性换气过度病因分类/
▸ 📁 主动脉夹层缺血表现识别/
▸ 📁 二尖瓣反流超声分级评估/
▸ 📁 亚硝酸盐中毒解救/
▸ 📁 他汀类药物临床应用/
▸ 📁 低血糖分层治疗与预防/
▸ 📁 侵袭性与慢性肺曲霉病抗真菌治疗/
▸ 📁 关节液白细胞计数鉴别关节炎类型/
▸ 📁 冻僵患者监护/
▸ 📁 分化型甲状腺癌术式选择/
▸ 📁 原发性甲旁亢手术适应证评估/
▸ 📁 同步与非同步电复律除颤决策/
▸ 📁 呼吸性碱中毒处理/
▸ 📁 巨幼细胞贫血诊断与试验性治疗验证/
▸ 📁 心脏压塞风险评估/
▸ 📁 心脏起搏器植入适应证评估/
▸ 📁 心脏骤停后脑复苏综合管理/
▸ 📁 心脏骤停电除颤操作/
▸ 📁 心血管系统功能与内分泌调节/
▸ 📁 急性中毒洗胃规范/
▸ 📁 急性乙醇中毒临床分期评估/
▸ 📁 急性心肌梗死β受体拮抗剂应用/
▸ 📁 急性心肌梗死心电图动态演变/
▸ 📁 急性心衰利尿剂与血管扩张剂应用/
▸ 📁 急性心衰正性肌力药物使用/
▸ 📁 急性糜烂出血性胃炎管理/
▸ 📁 急性胆囊炎诊断与并发症风险评估/
▸ 📁 急性胰腺炎诊断标准/
▸ 📁 急性间质性肾炎免疫抑制治疗决策/
▸ 📁 慢性腹泻分型诊断/
▸ 📁 成分输血选择与应用/
▸ 📁 房扑与房颤心电图鉴别/
▸ 📁 房颤与房扑抗凝决策/
▸ 📁 房颤心室率控制策略/
▸ 📁 扩张型心肌病诊断与鉴别/
▸ 📁 抗心律失常药物临床使用与安全监测/
▸ 📁 有机溶剂中毒多系统临床评估/
▸ 📁 消化性溃疡并发症识别/
▸ 📁 深静脉血栓诊断与抗凝/
▸ 📁 淹溺患者呼吸支持/
▸ 📁 热射病快速降温治疗/
▸ 📁 特定灭鼠药中毒救治/
▸ 📁 理化因素疾病诊断与防治/
▸ 📁 病毒性心肌炎诊断与特殊类型识别/
▸ 📁 糖尿病酮症酸中毒酸中毒严重程度评估/
▸ 📁 肝硬化病因分类与地域化诊断流程/
▸ 📁 肠结核与克罗恩病鉴别诊断/
▸ 📁 肾小球滤过率检测方法选择/
▸ 📁 肿瘤放疗后心脏瓣膜病监测与干预/
▸ 📁 胃镜结合黏膜活检诊断胃癌/
▸ 📁 胃黏膜屏障保护机制分析/
▸ 📁 胆囊结石风险评估/
▸ 📁 腹膜透析相关腹膜炎诊断与治疗/
▸ 📁 识别消化性溃疡的典型临床表现与节律性特征/
▸ 📁 钙通道阻滞剂选择与使用规范/
▸ 📁 镇静催眠药中毒救治/
▸ 📁 阿片类中毒纳洛酮应用/
▸ 📁 静脉补钾安全规范/
▸ 📁 高白细胞血症紧急处理/
▸ 📁 高血压急症控制性降压/
